Find Federal Grants
Centers for Disease Control and Prevention - ERA · RFA-CE-19-005
Health Resources and Services Administration · HRSA-19-071
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional)
National Institutes of Health · RFA-NS-19-014
National Institutes of Health · PAR-19-098
National Institutes of Health · RFA-AA-19-003
Health Resources and Services Administration · HRSA-19-001
Occupational Safety and Health Surveillance Collaboration, Education and Translation
Centers for Disease Control and Prevention - ERA · RFA-OH-19-002
HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-DA-19-035
HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional)
National Institutes of Health · RFA-RM-19-001
HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health · RFA-TR-19-003
HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required)
National Institutes of Health · RFA-MH-19-525
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-19-034
HEAL Initiative: Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · RFA-AT-19-006
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-19-028
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-19-023
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional)
National Institutes of Health · RFA-DA-19-024
HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health · RFA-DK-18-030
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)
National Institutes of Health · RFA-HL-19-029
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
National Institutes of Health · RFA-AT-19-004
Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-AT-19-005